Skip to main content

Table 4 Selected non-covalent interactions among chair ligands D–D5 and AChE obtained via flexible docking

From: Halogen-directed drug design for Alzheimer’s disease: a combined density functional and molecular docking study

Systems

Contacts

Bond distances (Å)

Systems

Contacts

Bond distances (Å)

D-AchE

C–H···O (Tyr70)

2.66

D3-TYMS

C–H···O (Asp72)

2.94

pi···pi (Trp84)

3.85

 

pi···pi (Trp84)

3.90, 4.01

pi···pi (Trp279)

4.14

 

pi···pi (Trp279)

4.41, 5.61

O···H–N (Phe288)

2.84

 

C–H···O (Ser286)

2.81

pi···pi (Phe330)

4.03

 

C–H···pi (Phe330)

2.33

pi···pi (Phe331)

5.30

 

pi···pi (Phe331)

5.43

pi···pi (Tyr334)

4.65

 

Alkyl···pi (Tyr334)

4.54

D1-AchE

C–H···O (Asp72)

2.90

D4-AChE

pi···pi (Trp84)

3.75

pi···pi (Trp84)

3.87, 3.98

 

Alkyl···pi (Phe330)

4.92

pi···pi (Trp279)

4.41, 5.66

 

Alkyl···pi (Phe331)

5.20

C–H···O (Ser286)

2.90

 

Alkyl···pi (Phe334)

5.41

C–H···pi (Phe330)

2.40

   

Alkyl···pi (Phe331)

5.41

   

Alkyl···pi (Tyr334)

4.53

   

D2- AchE

C–H···O (Asp72)

2.70

D5-AChE

C–H···O (Asp72)

2.74

pi···pi (Trp84)

3.89, 4.00

 

pi···pi (Trp84)

3.93, 4.17

pi···pi (Trp279)

4.35, 5.60

 

F···H–C, F···C (Gly117)

2.63, 3.17

C–H···O (Ser286)

3.00

 

F···H–O (Tyr130)

2.93

O···H–N (Phe288)

2.71

 

F···O (Glu199)

2.86, 2.91

C–H···pi (Phe330)

2.40

 

pi···pi (Trp279)

4.10

pi···pi (Phe331)

5.29

 

C–H···O (Ser286)

2.74

pi···pi (Phe334)

4.49

 

O–H···N (Phe288)

2.42

   

pi···pi (Phe330)

4.23

   

C–H···pi (Phe331)

2.92

   

pi···pi (Tyr334)

4.44

  1. Brackets indicate the amino acid residues that are in contact with the ligands
  2. Asp asparatic acid, Gly glycine, Glu glutamine, Phe phenylalanine, Ser serine, Trp tryptophan, Tyr tyrosine